Tracking Leon Cooperman's Omega Advisors Portfolio - Q2 2026 Update
SeekingAlphayesterdayELV
UnitedHealth Stock Recovered Before Its Margins Did
UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.
YahooyesterdayELV
CVS Stock Has Left Its Peers Behind. Or Has It?
The market has crowned this healthcare giant the winner of its group, but a look at the underlying business raises the question of whether the celebration started too soon.
YahooyesterdayELV
Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?
CNC's 117% rally now has support from improving margins, firmer pricing and higher earnings expectations, while valuation remains below key peers.
Yahoo2 days agoELV
How Is Elevance Health’s Stock Performance Compared to Other Health Providers?
Elevance Health has underperformed its industry peers over the past year, but analysts are moderately optimistic about the stock’s prospects.
Yahoo2 days agoELV
Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability
First Eagle Investment Management, an investment management company, released its Q2 2026 investor update for “First Eagle Global Fund”. The letter can be downloaded here. Easing tensions in the Middle East led to a strong rally in risk markets in Q2. The S&P 500 Index rose 15.2%, while the MSCI EAFE Index gained 10.8%. Growth […]
Yahoo3 days agoELV
Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report?
Medpace (MEDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yahoo14 days agoELV
Can Humana's Star Ratings Rebound Unlock MA Earnings Power?
HUM's Star Ratings recovery is set to show early progress, but October's CMS release will test its MA turnaround and path to a 2028 margin target.
Yahoo15 days agoELV
How Should You Approach CVS Health Stock After Q2 Earnings?
CVS delivers strong Q2 growth and raises 2026 targets, but Caremark pressures and medical costs are likely to shape its next move.
Yahoo17 days agoELV
Warren Buffett Disciple Seth Klarman Bets on Cruise Lines, Auto Parts, Amazon and Bill Ackman in Q2
Value investor Seth Klarman reveals his latest stock picks in a second quarter filing for hedge fund Baupost Group.
Benzinga17 days agoELV
Is Elevance Health (ELV) Still A Bargain After A 38% Gain?
Elevance Health has delivered a 37.6% gain over the past year, yet current valuation checks still lean on the side of the stock looking inexpensive rather than stretched. For investors, that creates a pricing debate around how much of the company’s recent health data partnerships and care model initiatives is already reflected in today’s US$398.22 share price. Over the last 12 months Elevance Health is up 37.6%. This puts recent shareholders in a comfortable spot and raises the bar for what...
Yahoo21 days agoELV